The only thing that worries me is if the hospitals in
the US that have been nominated to run the Covid
trials, some may not be in the high infection areas.
If they can quickly change the point of attack, then
no problem, but if not, recruitment could be slower
than first expected and results for initial 90 could
be later than expected. I guess we will soon know.
Ann: Ethics Approval to Treat COVID-19 Patients in Australia, page-192
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
-0.210(11.8%) |
Mkt cap ! $1.792B | |||
| Open | High | Low | Value | Volume |
| $1.72 | $1.74 | $1.52 | $15.63M | 9.716M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5127 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.57 | 39613 | 3 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |